Bank of Montreal
KIN

Bank of Montreal’s Kindred Biosciences, Inc. KIN Stock Holding History

Bank of Montreal’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,289
Closed -$12K – 5460
2021
Q1 		$12K Sell
2,289
-4,728
-67% -$22.8K ﹤0.01% 4307
2020
Q4 		$33K Buy
7,017
+3,949
+129% +$16.1K ﹤0.01% 4176
2020
Q3 		$14K Sell
3,068
-1,288
-30% -$5.38K ﹤0.01% 4006
2020
Q2 		$17K Buy
4,356
+2,585
+146% +$11.6K ﹤0.01% 3935
2020
Q1 		$7K Sell
1,771
-4,703
-73% -$39.9K ﹤0.01% 3621
2019
Q4 		$55K Buy
6,474
+3,229
+100% +$25.2K ﹤0.01% 3798
2019
Q3 		$22K Sell
3,245
-260
-7% -$1.91K ﹤0.01% 4054
2019
Q2 		$29K Buy
3,505
+3,363
+2,368% +$29K ﹤0.01% 3967
2019
Q1 		$1K Sell
142
-337
-70% -$3.42K ﹤0.01% 4240
2018
Q4 		$5K Buy
479
+225
+89% +$2.83K ﹤0.01% 4123
2018
Q3 		$4K Buy
254
+30
+13% +$406 ﹤0.01% 4194
2018
Q2 		$2K Buy
224
+184
+460% +$1.79K ﹤0.01% 4449
2018
Q1 		$0 Hold
40
– – ﹤0.01% 4425
2017
Q4 		$0 Hold
40
– – ﹤0.01% 4402
2017
Q3 		$0 Hold
40
– – ﹤0.01% 4379
2017
Q2 		$0 Buy
40
+37
+1,233% +$265 ﹤0.01% 4346
2017
Q1 		$0 Buy
+3
New +$19 ﹤0.01% 4272
2016
Q4 		– Sell
-440
Closed -$2K – 4252
2016
Q3 		$2K Buy
440
+422
+2,344% +$1.78K ﹤0.01% 3879
2016
Q2 		$0 Sell
18
-303
-94% -$1.11K ﹤0.01% 4410
2016
Q1 		$1K Sell
321
-29
-8% -$102 ﹤0.01% 4121
2015
Q4 		$1K Buy
350
+274
+361% +$1.27K ﹤0.01% 4139
2015
Q3 		$0 Sell
76
-1
-1% -$6 ﹤0.01% 4227
2015
Q2 		$1K Buy
77
+21
+38% +$149 ﹤0.01% 3870
2015
Q1 		$0 Hold
56
– – ﹤0.01% 4270
2014
Q4 		$0 Sell
56
-21,439
-100% -$182K ﹤0.01% 4234
2014
Q3 		$199K Buy
21,495
+21,235
+8,167% +$287K ﹤0.01% 2536
2014
Q2 		$5K Buy
+260
New +$4.42K ﹤0.01% 4196

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Bank of Montreal's KIN Position: Q2 2021 in Review

Bank of Montreal sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 2,289 shares — an estimated $12K sold.

Bank of Montreal first reported a position in KIN in Q2 2014 and held it in 27 quarters. The position peaked at $199K in Q3 2014. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • Bank of Montreal reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,289 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $12K.
  • Bank of Montreal first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 27 quarters.
  • Bank of Montreal's Kindred Biosciences, Inc. position peaked at $199K in Q3 2014.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.